AU4245097A - Multivalent vaccine for (clostridium botulinum) neurotoxin - Google Patents

Multivalent vaccine for (clostridium botulinum) neurotoxin

Info

Publication number
AU4245097A
AU4245097A AU42450/97A AU4245097A AU4245097A AU 4245097 A AU4245097 A AU 4245097A AU 42450/97 A AU42450/97 A AU 42450/97A AU 4245097 A AU4245097 A AU 4245097A AU 4245097 A AU4245097 A AU 4245097A
Authority
AU
Australia
Prior art keywords
neurotoxin
clostridium botulinum
multivalent vaccine
multivalent
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42450/97A
Inventor
Bruce S Thalley
James A. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ophidian Pharmaceuticals Inc
Original Assignee
Ophidian Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/704,159 external-priority patent/US6967088B1/en
Application filed by Ophidian Pharmaceuticals Inc filed Critical Ophidian Pharmaceuticals Inc
Publication of AU4245097A publication Critical patent/AU4245097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU42450/97A 1996-08-28 1997-08-28 Multivalent vaccine for (clostridium botulinum) neurotoxin Abandoned AU4245097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/704,159 US6967088B1 (en) 1995-03-16 1996-08-28 Soluble recombinant botulinum toxin proteins
US08704159 1996-08-28
PCT/US1997/015394 WO1998008540A1 (en) 1996-08-28 1997-08-28 Multivalent vaccine for clostridium botulinum neurotoxin

Publications (1)

Publication Number Publication Date
AU4245097A true AU4245097A (en) 1998-03-19

Family

ID=24828333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42450/97A Abandoned AU4245097A (en) 1996-08-28 1997-08-28 Multivalent vaccine for (clostridium botulinum) neurotoxin

Country Status (4)

Country Link
EP (1) EP1105153A4 (en)
AU (1) AU4245097A (en)
CA (1) CA2296765A1 (en)
WO (1) WO1998008540A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
US8012491B2 (en) 1996-08-23 2011-09-06 Syntaxin, Ltd. Recombinant toxin fragments
US7192596B2 (en) 1996-08-23 2007-03-20 The Health Protection Agency Ipsen Limited Recombinant toxin fragments
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
ATE382693T1 (en) * 1998-07-10 2008-01-15 U S Army Medical Res Inst Of I VACCINES AGAINST CLOSTRIDIUM BOTULINUM NEUROTOXINS
AU4641299A (en) * 1998-07-22 2000-02-14 Agricultural Research Council Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin
US20040071736A1 (en) 1998-08-25 2004-04-15 Health Protection Agency Methods and compounds for the treatment of mucus hypersecretion
GB9818548D0 (en) 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion
GB9907429D0 (en) 1999-03-31 1999-05-26 Microbiological Res Authority Modulation of C-fibre activity
CA2380457A1 (en) 1999-08-25 2001-03-01 Allergan Sales, Inc. Activatable recombinant neurotoxins
US7740868B2 (en) 1999-08-25 2010-06-22 Allergan, Inc. Activatable clostridial toxins
US20080038274A1 (en) 1999-09-23 2008-02-14 Foster Keith A Inhibition of secretion from non-neuronal cells
US7691983B2 (en) 2000-07-21 2010-04-06 Allergan, Inc. Chimera botulinum toxin type E
AU2002228887B2 (en) * 2000-11-06 2006-08-24 United States Army Medical Research And Material Command Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
JP3995541B2 (en) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション Anti-chicken coccidiosis composition
US20050042775A1 (en) * 2003-08-21 2005-02-24 Nicholas Pomato Botulinum antitoxin compositions and methods
GB2456549A (en) * 2008-01-18 2009-07-22 Health Prot Agency Modified botulinum neurotoxin serotype E (BoNT/E) peptides
WO2009152452A1 (en) * 2008-06-12 2009-12-17 Huei-Hsiung Yang Fermentation method for the production of soluble botulinum neurotoxin proteins
RU2014127714A (en) 2011-12-08 2016-01-27 Новартис Аг TOXIN VACCINE Clostridium difficile
DK3372239T3 (en) 2012-05-30 2021-02-01 Harvard College MANIPULATED BOTULINUM NEUROTOXIN
EP3981783A1 (en) 2015-03-26 2022-04-13 President And Fellows Of Harvard College Engineered botulinum neurotoxin
KR20180021703A (en) 2015-05-15 2018-03-05 보드 오브 리젠츠 오브 디 유니버시티 오브 네브라스카 The engineered Clostridium botulinum toxin, modified to deliver the molecule to selected cells
WO2018039506A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Engineered botulinum neurotoxin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005222A1 (en) * 1994-08-08 1996-02-22 Wisconsin Alumni Research Foundation Purification and pharmaceutical compositions containing type g botulinum neurotoxin
CZ296806B6 (en) * 1994-10-24 2006-06-14 Allergan, Inc. Soluble fusion protein and process for preparing soluble recombinant botulin toxin

Also Published As

Publication number Publication date
EP1105153A4 (en) 2005-01-19
EP1105153A1 (en) 2001-06-13
WO1998008540A1 (en) 1998-03-05
CA2296765A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AU4245097A (en) Multivalent vaccine for (clostridium botulinum) neurotoxin
AU2103797A (en) Clostridium perfringens vaccines
AU3821497A (en) Methods for isolating nucleic acids using alkaline protease
AU1848597A (en) Emulation repair system
AU6051798A (en) Method and system for injecting new code into existing application code
AU4781297A (en) Vaccines
AU3773297A (en) Intradermal bovine polynucleotide vaccine
AU3593697A (en) Asymmetrical drive system
AU3992697A (en) Pharmaceutical preparations for intranasal administration
HK1083736A1 (en) Immunization against clostridium difficile disease
AU1847497A (en) Protein expression system
HK1019499A1 (en) Optical disc and optical disc driving apparatus.
AU3058397A (en) Information system
AU4391197A (en) Sealing system
AU8348298A (en) Split-key cryptographic system and method
AU4528496A (en) Method for generating proteolytic enzymes specific against selected peptide sequence
HUP9801384A3 (en) Clostridium perfringens vaccine
AU5256998A (en) Electrophoresis system
AUPO182396A0 (en) Improved nucleic acids for reducing carbohydrate epitopes
AU7361798A (en) Method and system for wavelength division multiplexer
AU4747997A (en) Interstitial sector system
AU4879797A (en) Optical system for head up display
AU3552797A (en) Vaccine preparations
AU4641299A (en) Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin
GB2327291B (en) Optical system for optical disk drive